Journal of Pharmaceutical Analysis (Apr 2020)

Molecular immune pathogenesis and diagnosis of COVID-19

  • Xiaowei Li,
  • Manman Geng,
  • Yizhao Peng,
  • Liesu Meng,
  • Shemin Lu

Journal volume & issue
Vol. 10, no. 2
pp. 102 – 108

Abstract

Read online

Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection. Keywords: Coronavirus, SARS-CoV-2, SARS-CoV, MERS-CoV, Pathogenesis